November 20, 2020—The purpose of this guideline is to commission a full guideline revision of the 2011 ACCF/ AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy. This version replaces the 2011 guideline and addresses comprehensive evaluation and management of adults and children with hypertrophic cardiomyopathy. Diagnostic modalities such as electrocardiography, imaging and genetic testing, and management of patients include medical therapies, septal reduction therapies, sudden cardiac death risk assessment/prevention, and lifestyle considerations such as participation in activities/sports, occupation, and pregnancy.
HRS Endorsed
- Yes
Topic
- Clinical Topics
- Device Therapy
- Electrophysiology
- Hypertrophic Cardiomyopathy
- Pediatric
Resource Type
- Clinical Guidelines
Related Resources

Clinical Guidelines
18F-FDG PET/CT and Radiolabeled Leukocyte SPECT/CT Imaging for the Evaluation of Cardiovascular Infection in the Multimodality Context
The American Society of Nuclear Cardiology (ASNC) and Heart Rhythm Society (HRS), in partnership with 9 other societies, have released a consensus statement on the…
March 11, 2024

Clinical Guidelines
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Patients With Atrial Fibrillation
The American College of Cardiology (ACC) and American Heart Association (AHA) released updated recommendations for preventing and managing atrial fibrillation. The new guideline was developed…
November 30, 2023

Clinical Guidelines
2003 NASPE Training Requirements for Cardiac Implantable Electronic Devices: Selection, Implantation, and Follow-Up
This statement provides additional information regarding maintenance of skills related to device implantation, more detailed training guidelines for CIED implantation and lead extraction, and initial…
July 1, 2023